Influenza Therapeutics Market - Global Outlook and Forecast 2023-2028

Report ID: 1566675 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Influenza Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Influenza Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Influenza Therapeutics Overall Market Size
    2.1 Global Influenza Therapeutics Market Size: 2021 VS 2028
    2.2 Global Influenza Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Influenza Therapeutics Players in Global Market
    3.2 Top Global Influenza Therapeutics Companies Ranked by Revenue
    3.3 Global Influenza Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Influenza Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Influenza Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Influenza Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Influenza Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Influenza Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Influenza Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Vaccines
        4.1.3 Drugs
    4.2 By Type - Global Influenza Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Influenza Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Influenza Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Influenza Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Influenza Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Influenza Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Influenza Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Influenza Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Influenza Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Influenza Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Influenza Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Influenza Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Influenza Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Influenza Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Influenza Therapeutics Revenue, 2017-2028
        6.3.2 US Influenza Therapeutics Market Size, 2017-2028
        6.3.3 Canada Influenza Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Influenza Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Influenza Therapeutics Revenue, 2017-2028
        6.4.2 Germany Influenza Therapeutics Market Size, 2017-2028
        6.4.3 France Influenza Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Influenza Therapeutics Market Size, 2017-2028
        6.4.5 Italy Influenza Therapeutics Market Size, 2017-2028
        6.4.6 Russia Influenza Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Influenza Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Influenza Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Influenza Therapeutics Revenue, 2017-2028
        6.5.2 China Influenza Therapeutics Market Size, 2017-2028
        6.5.3 Japan Influenza Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Influenza Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Influenza Therapeutics Market Size, 2017-2028
        6.5.6 India Influenza Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Influenza Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Influenza Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Influenza Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Influenza Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Influenza Therapeutics Market Size, 2017-2028
        6.7.3 Israel Influenza Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Influenza Therapeutics Market Size, 2017-2028
        6.7.5 UAE Influenza Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Corporate Summary
        7.1.2 Abbott Laboratories Business Overview
        7.1.3 Abbott Laboratories Influenza Therapeutics Major Product Offerings
        7.1.4 Abbott Laboratories Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Abbott Laboratories Key News
    7.2 Astrazeneca PLC
        7.2.1 Astrazeneca PLC Corporate Summary
        7.2.2 Astrazeneca PLC Business Overview
        7.2.3 Astrazeneca PLC Influenza Therapeutics Major Product Offerings
        7.2.4 Astrazeneca PLC Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Astrazeneca PLC Key News
    7.3 Biocryst Pharmaceuticals, Inc.
        7.3.1 Biocryst Pharmaceuticals, Inc. Corporate Summary
        7.3.2 Biocryst Pharmaceuticals, Inc. Business Overview
        7.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Major Product Offerings
        7.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Biocryst Pharmaceuticals, Inc. Key News
    7.4 Chiron Corporation
        7.4.1 Chiron Corporation Corporate Summary
        7.4.2 Chiron Corporation Business Overview
        7.4.3 Chiron Corporation Influenza Therapeutics Major Product Offerings
        7.4.4 Chiron Corporation Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Chiron Corporation Key News
    7.5 CSL Limited
        7.5.1 CSL Limited Corporate Summary
        7.5.2 CSL Limited Business Overview
        7.5.3 CSL Limited Influenza Therapeutics Major Product Offerings
        7.5.4 CSL Limited Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 CSL Limited Key News
    7.6 Daiichi Sankyo Co., Ltd.
        7.6.1 Daiichi Sankyo Co., Ltd. Corporate Summary
        7.6.2 Daiichi Sankyo Co., Ltd. Business Overview
        7.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Major Product Offerings
        7.6.4 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 Daiichi Sankyo Co., Ltd. Key News
    7.7 Glaxosmithkline PLC
        7.7.1 Glaxosmithkline PLC Corporate Summary
        7.7.2 Glaxosmithkline PLC Business Overview
        7.7.3 Glaxosmithkline PLC Influenza Therapeutics Major Product Offerings
        7.7.4 Glaxosmithkline PLC Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Glaxosmithkline PLC Key News
    7.8 Mitsubishi Tanabe Pharma Corporation
        7.8.1 Mitsubishi Tanabe Pharma Corporation Corporate Summary
        7.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview
        7.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Major Product Offerings
        7.8.4 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Mitsubishi Tanabe Pharma Corporation Key News
    7.9 Nanotherapeutics Inc.
        7.9.1 Nanotherapeutics Inc. Corporate Summary
        7.9.2 Nanotherapeutics Inc. Business Overview
        7.9.3 Nanotherapeutics Inc. Influenza Therapeutics Major Product Offerings
        7.9.4 Nanotherapeutics Inc. Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Nanotherapeutics Inc. Key News
    7.10 Protein Sciences Corporation
        7.10.1 Protein Sciences Corporation Corporate Summary
        7.10.2 Protein Sciences Corporation Business Overview
        7.10.3 Protein Sciences Corporation Influenza Therapeutics Major Product Offerings
        7.10.4 Protein Sciences Corporation Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 Protein Sciences Corporation Key News
    7.11 Roche Holding AG
        7.11.1 Roche Holding AG Corporate Summary
        7.11.2 Roche Holding AG Business Overview
        7.11.3 Roche Holding AG Influenza Therapeutics Major Product Offerings
        7.11.4 Roche Holding AG Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.11.5 Roche Holding AG Key News
    7.12 Sanofi SA
        7.12.1 Sanofi SA Corporate Summary
        7.12.2 Sanofi SA Business Overview
        7.12.3 Sanofi SA Influenza Therapeutics Major Product Offerings
        7.12.4 Sanofi SA Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.12.5 Sanofi SA Key News
    7.13 Shionogi & Co., Ltd.
        7.13.1 Shionogi & Co., Ltd. Corporate Summary
        7.13.2 Shionogi & Co., Ltd. Business Overview
        7.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Major Product Offerings
        7.13.4 Shionogi & Co., Ltd. Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.13.5 Shionogi & Co., Ltd. Key News
    7.14 Sinovac Biotech Ltd.
        7.14.1 Sinovac Biotech Ltd. Corporate Summary
        7.14.2 Sinovac Biotech Ltd. Business Overview
        7.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Major Product Offerings
        7.14.4 Sinovac Biotech Ltd. Influenza Therapeutics Revenue in Global Market (2017-2022)
        7.14.5 Sinovac Biotech Ltd. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Influenza Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Influenza Therapeutics Market Drivers in Global Market
    Table 3. Influenza Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Influenza Therapeutics in Global Market
    Table 5. Top Influenza Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Influenza Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Influenza Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Influenza Therapeutics Product Type
    Table 9. List of Global Tier 1 Influenza Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Influenza Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Influenza Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Influenza Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Influenza Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Influenza Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Influenza Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Influenza Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Influenza Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Influenza Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Influenza Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Influenza Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Influenza Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Influenza Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Influenza Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Influenza Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Influenza Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Influenza Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Influenza Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Influenza Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Influenza Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Laboratories Corporate Summary
    Table 31. Abbott Laboratories Influenza Therapeutics Product Offerings
    Table 32. Abbott Laboratories Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Astrazeneca PLC Corporate Summary
    Table 34. Astrazeneca PLC Influenza Therapeutics Product Offerings
    Table 35. Astrazeneca PLC Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Biocryst Pharmaceuticals, Inc. Corporate Summary
    Table 37. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Offerings
    Table 38. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Chiron Corporation Corporate Summary
    Table 40. Chiron Corporation Influenza Therapeutics Product Offerings
    Table 41. Chiron Corporation Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. CSL Limited Corporate Summary
    Table 43. CSL Limited Influenza Therapeutics Product Offerings
    Table 44. CSL Limited Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. Daiichi Sankyo Co., Ltd. Corporate Summary
    Table 46. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Offerings
    Table 47. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Glaxosmithkline PLC Corporate Summary
    Table 49. Glaxosmithkline PLC Influenza Therapeutics Product Offerings
    Table 50. Glaxosmithkline PLC Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. Mitsubishi Tanabe Pharma Corporation Corporate Summary
    Table 52. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Offerings
    Table 53. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. Nanotherapeutics Inc. Corporate Summary
    Table 55. Nanotherapeutics Inc. Influenza Therapeutics Product Offerings
    Table 56. Nanotherapeutics Inc. Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 57. Protein Sciences Corporation Corporate Summary
    Table 58. Protein Sciences Corporation Influenza Therapeutics Product Offerings
    Table 59. Protein Sciences Corporation Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 60. Roche Holding AG Corporate Summary
    Table 61. Roche Holding AG Influenza Therapeutics Product Offerings
    Table 62. Roche Holding AG Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 63. Sanofi SA Corporate Summary
    Table 64. Sanofi SA Influenza Therapeutics Product Offerings
    Table 65. Sanofi SA Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 66. Shionogi & Co., Ltd. Corporate Summary
    Table 67. Shionogi & Co., Ltd. Influenza Therapeutics Product Offerings
    Table 68. Shionogi & Co., Ltd. Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 69. Sinovac Biotech Ltd. Corporate Summary
    Table 70. Sinovac Biotech Ltd. Influenza Therapeutics Product Offerings
    Table 71. Sinovac Biotech Ltd. Influenza Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Influenza Therapeutics Segment by Type in 2021
    Figure 2. Influenza Therapeutics Segment by Application in 2021
    Figure 3. Global Influenza Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Influenza Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Influenza Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Influenza Therapeutics Revenue in 2021
    Figure 8. By Type - Global Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Influenza Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Influenza Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Laboratories Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Astrazeneca PLC Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Chiron Corporation Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. CSL Limited Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Glaxosmithkline PLC Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Nanotherapeutics Inc. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Protein Sciences Corporation Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Roche Holding AG Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Sanofi SA Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Shionogi & Co., Ltd. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Sinovac Biotech Ltd. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Influenza Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Influenza Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Influenza Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports